The FDA announced on June 6, 2014, that Hospira Inc. voluntarily recalled Heparin Sodium Injection due to a lack of sterility assurance confirmed by a consumer report of fluid leaking from the primary container bag. Owners should contact the company for a refund.
How to tell if you have it
- Brand: Hospira
- Product: Heparin Sodium in 5% Dextrose Injection, Heparin, 25,000 USP Heparin Units/250 mL (100 USP Heparin Units/mL), 250 mL, Single-Dose Container
- NDC: 0409-7793-62
- Lot codes: 34-811-KL, 36-106-KL, 36-114-KL, 36-101-KL, 37-202-KL, 38-302-KL, 38-305-KL
- Expiration dates: 12/15, 1/16, 2/16
- Quantity: 142,152 bags
The hazard
The recall addresses a lack of assurance of sterility caused by confirmed consumer reports of fluid leaking from the primary container bag, which poses an infection risk.
Context
GovInfoNow's records show Hospira Inc. has issued 108 other recalls since April 5, 2012. Other recent recalls include a 2017-04-21 recall for hair particulates in Infant Dextrose Injection and a 2016-11-01 recall for broken ampule tips on Fentanyl Injection. Additional similar product recalls include a 2026-03-11 Fresenius Kabi Sodium Chloride Injection recall for lack of sterility assurance and a 2026-04-24 Teva Octreotide Acetate Kit recall for sterility risk.